BOUDREAUX GAIL (CIK 1287920) reported 12 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-03-13). Recent activity: Buy TGT (2,682 shares), Sell ELV (6,713 shares), Buy ELV (16,153 shares), Buy ELV (10,527 shares), Sell ELV (1,736 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-13 | TARGET CORP (TGT) | Director | Buy | 2,682 | $0 |
| 2026-03-04 | Elevance Health, Inc. (ELV) | President and CEO | Sell | 6,713 | $2.0M |
| 2026-03-04 | Elevance Health, Inc. (ELV) | President and CEO | Buy | 16,153 | $0 |
| 2026-03-04 | Elevance Health, Inc. (ELV) | President and CEO | Buy | 10,527 | $0 |
| 2026-03-04 | Elevance Health, Inc. (ELV) | President and CEO | Sell | 1,736 | $493,076 |
| 2025-07-18 | Elevance Health, Inc. (ELV) | President and CEO | Buy | 2,334 | $667,687 |
| 2025-07-18 | Elevance Health, Inc. (ELV) | President and CEO | Buy | 5,116 | $1.5M |
| 2025-07-18 | Elevance Health, Inc. (ELV) | President and CEO | Buy | 1,050 | $302,358 |
| 2025-03-14 | TARGET CORP (TGT) | Director | Buy | 2,946 | $0 |
| 2025-03-05 | Elevance Health, Inc. (ELV) | President and CEO | Sell | 10,396 | $4.1M |
| 2025-03-05 | Elevance Health, Inc. (ELV) | President and CEO | Buy | 10,620 | $0 |
| 2025-03-05 | Elevance Health, Inc. (ELV) | President and CEO | Buy | 15,587 | $0 |
Source: SEC Form 4 filings · as of 2026-03-13